Analysts Upgrade Ratings for Monopar and Other Stocks This Week

Several prominent analysts on Wall Street have updated their outlooks on key stocks this week, initiating coverage with bullish ratings. This trend includes notable recommendations for companies such as Monopar Therapeutics Inc. and GH Research PLC, among others.

Analyst Ratings Overview

According to a report from Benzinga, analysts are making strategic moves as they initiate coverage on various stocks. Notably, Needham analyst Ami Fadia began coverage on GH Research PLC (NASDAQ:GHRS) with a Buy rating, setting a price target of $19. As of the last trading session on Friday, the shares closed at $12.59, indicating significant upside potential.

In a separate analysis, BTIG analyst Gray Powell initiated coverage on Netskope, Inc. (NASDAQ:NTSK) with a Buy rating and set a price target of $27. The stock was trading at $21.75 on Friday, suggesting a favorable investment outlook.

Focus on Monopar Therapeutics

Barclays has joined the mix, with analyst Etzer Darout initiating coverage on Monopar Therapeutics Inc. (NASDAQ:MNPR) with an Overweight rating and a price target of $125. Shares of Monopar closed at $87.82 on Friday, reflecting a robust potential for growth in the eyes of analysts.

Additionally, Goldman Sachs analyst John Mackay initiated coverage of WaterBridge Infrastructure LLC (NYSE:WBI) with a Neutral rating and a price target of $21. The stock closed at $24.17 on Friday, indicating a cautious but stable outlook.

Lastly, Berenberg analyst Kai Klose initiated coverage on NETSTREIT Corp. (NYSE:NTST) with a Buy rating and a price target of $22. The shares were trading at $18.21 at the end of the trading week, suggesting an attractive entry point for investors.

As these analysts weigh in on the performance of various stocks, investors are encouraged to consider their insights and the underlying market dynamics. For those contemplating investments in Monopar or other highlighted stocks, the latest ratings may provide valuable guidance.

For a comprehensive view of all analyst rating changes, including upgrades and downgrades, interested parties can refer to relevant resources.